327 related articles for article (PubMed ID: 31706505)
1. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
Arneson PC; Doles JD
Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
[TBL] [Abstract][Full Text] [Related]
2. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
Talbert EE; Guttridge DC
Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
[TBL] [Abstract][Full Text] [Related]
3. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
[TBL] [Abstract][Full Text] [Related]
4. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
5. Muscle wasting in cancer: the role of mitochondria.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
[TBL] [Abstract][Full Text] [Related]
6. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
7. Muscle atrophy is not always sarcopenia.
Hepple RT
J Appl Physiol (1985); 2012 Aug; 113(4):677-9. PubMed ID: 22518833
[No Abstract] [Full Text] [Related]
8. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
[TBL] [Abstract][Full Text] [Related]
9. Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines.
Arneson-Wissink PC; Doles JD
Exp Cell Res; 2021 Oct; 407(1):112779. PubMed ID: 34428455
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle regeneration in cancer cachexia.
Bossola M; Marzetti E; Rosa F; Pacelli F
Clin Exp Pharmacol Physiol; 2016 May; 43(5):522-7. PubMed ID: 26857538
[TBL] [Abstract][Full Text] [Related]
11. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia.
Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.
Vitorino R; Moreira-Gonçalves D; Ferreira R
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):226-33. PubMed ID: 25783794
[TBL] [Abstract][Full Text] [Related]
13. Physiological characterization of a mouse model of cachexia in colorectal liver metastases.
Murphy KT; Struk A; Malcontenti-Wilson C; Christophi C; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R854-64. PubMed ID: 23485871
[TBL] [Abstract][Full Text] [Related]
14. Loss of oxidative defense and potential blockade of satellite cell maturation in the skeletal muscle of patients with cancer but not in the healthy elderly.
Brzeszczyńska J; Johns N; Schilb A; Degen S; Degen M; Langen R; Schols A; Glass DJ; Roubenoff R; Greig CA; Jacobi C; Fearon KCh; Ross JA
Aging (Albany NY); 2016 Aug; 8(8):1690-702. PubMed ID: 27454226
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass.
Cassano M; Quattrocelli M; Crippa S; Perini I; Ronzoni F; Sampaolesi M
J Muscle Res Cell Motil; 2009 Dec; 30(7-8):243-53. PubMed ID: 20195710
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of metabolic dysfunction in cancer-associated cachexia.
Petruzzelli M; Wagner EF
Genes Dev; 2016 Mar; 30(5):489-501. PubMed ID: 26944676
[TBL] [Abstract][Full Text] [Related]
17. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
Dolly A; Dumas JF; Servais S
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1413-1428. PubMed ID: 33053604
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
[TBL] [Abstract][Full Text] [Related]
19. Assessing Metabolic Dysregulation in Muscle During Cachexia.
Hsu MY; Porporato PE; Wyart E
Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
[TBL] [Abstract][Full Text] [Related]
20. The mechanisms of cachexia underlying muscle dysfunction in COPD.
Remels AH; Gosker HR; Langen RC; Schols AM
J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
